|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Emerging picture of multiple sclerosis in Kenya 显示文摘 | Kioy PG | 2001 | East Afr Med J2001，78，2： | 1 |
| 2 | Targeting IL-13Ralpha2- positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin 显示文摘 | Kioi M Seetharam S Puri RK | 2008 | Mol Cancer Ther2008，7，6： | 1 |
| 3 | Age-structured model for COVID-19: Effectiveness of social distancing and contact reduction in Kenya显示文摘Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2.Kenya reported its first case on March 13,2020 and by March 16,2020 she instituted physical distancing strategies to reduce transmission and flatten the epidemic curve.An age-structured compartmental model was developed to assess the impact of the strategies on COVID-19 severity and burden.Contacts between different ages are incorporated via contact matrices.Simulation results show that 45%reduction in contacts for 60-days period resulted to 11.5e13%reduction of infections severity and deaths,while for the 190-days period yielded 18.8e22.7%reduction.The peak of infections in the 60-days mitigation was higher and happened about 2 months after the relaxation of mitigation as compared to that of the 190-days mitigation,which happened a month after mitigations were relaxed.Low numbers of cases in children under 15 years was attributed to high number of asymptomatic cases.High numbers of cases are reported in the 15e29 years and 30e59 years age bands.Two mitigation periods,considered in the study,resulted to reductions in severe and critical cases,attack rates,hospital and ICU bed demands,as well as deaths,with the 190-days period giving higher reductions. | Mark Kimathi Samuel Mwalili Viona Ojiambo Duncan Kioi Gathungu | 2021 | Infectious Disease Modelling2021，6，1： | 1 |
| 4 | Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice 显示文摘 | Kioi M Vogel H Schultz G | 2010 | J CIin Invest2010，120，3： | 1 |
| 5 | Emerging picture of multiple sclerosis in Kenya 显示文摘 | Kioy PG | 2001 | East Afr Med J2001，78，2： | 1 |
| 6 | Interleukin-13 receptor alpha2 chain:a potential biomarker and molecular target for ovarian cancer therapy显示文摘 | Kioi M Kawakami M Shimamura T | | 0，，06： | 1 |
| 7 | Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy 显示文摘 | Kioi M Husain SR Croteau D | 2006 | Technol Cancer Res Treat2006，5，3： | 1 |
| 8 | Identification of potential therapeutic targets in human head & neck squamous cell carcinoma 显示文摘 | HAN J KIOI M CHU W S | 2009 | Head Neck Oneol2009，1，1： | 1 |
| 9 | Optimized clostridia-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA-cmss-linking agent PR-104 显示文摘 | Liu SC Ahn GO Mitomu Kioi | 2008 | Cancer Res2008，68，19： | 1 |
| 10 | Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice显示文摘 | Kioi M Vogel H Sehultz G | 2010 | J Clin Invest2010，120，3： | 1 |
| 11 | Targeting IL-13Ralpha2- positive cancer with a novel recombinant immunotoxin com- posed of a single-chain antibody and mutated Pseudomonas exotoxin 显示文摘 | Kioi M Seetharam S Puri RK | 2008 | Mol Cancer Ther2008，7，6： | 1 |
| 12 | Hodgkin Lymphoma Therapy with Interleukin-4 Receptor-directed Cytotoxin In an Infiltrating Animal Model 显示文摘 | Kawakami M Kawakami K Kioi M | 2005 | Blood2005，105，9： | 1 |
| 13 | Inhibition of vaseulogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irra- diation in mice显示文摘 | Kioi M Vogel H Schultz G | 2010 | J Clin Invest2010，120，3： | 1 |
| 14 | Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy显示文摘 | Kioi M Kawakami M Shimamura T | 2006 | Cancer2006，107，6： | 1 |
| 15 | Targeting IL-13Ralpha2-positive cancer with a novel recombinant immunotoxin composed of a singlechain antibody and mutated Pseudomonas exotoxin 显示文摘 | Kioi M Seetharam S Purl RK | 2008 | Mol Cancer Ther2008，7，6： | 1 |
| 16 | The unique role of natural killer Tcells inthe response to microorganisms显示文摘 | Tupin E KioY Kronenberg M | 2007 | N&true Eev Micro2007，5，5： | 1 |
| 17 | Targeting IL-13Ralpha2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin显示文摘 | Kioi M Seetharam S Purl RK | 2008 | Mol Cancer Ther2008，7，6： | 1 |
| 18 | Optimized Clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104显示文摘 | Liu SC Ahn GO Kioi M | 2008 | Cancer Res2008，68，9： | 1 |
| 19 | Evidence that IL-13R alpha2 chain in human glioma cells is responsible for the antitumor activity mediated by receptor directed cytotoxin therapy 显示文摘 | Kawakami K Kioi M Liu Q | 2005 | J Immunother2005，28，3： | 1 |
| 20 | Identification of potential therapeutic targets in human head & neck squamous cellcarcinoma显示文摘 | Han J Kioi M Chu WS | 2009 | Head Neck Oncol2009，1，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员